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statement of a recently published Cochrane review that has evalu-
ated the data of 19 randomized clinical trials with a total of 6,264 
patients involved [5].
The multidisciplinary approach describes teamwork of multiple 
disciplines to ‘redefine problems outside of normal boundaries and 
reach solutions based on a new understanding of complex situa-
tions’ (http://en.wikipedia.org/wiki/Multidisciplinary_approach). 
This definition of the free encyclopedia Wikipedia perfectly fits 
with the challenges of patient blood management. To increase the 
overall effectiveness specialists of as many disciplines as possible 
need participating in patient blood management programs. This 
includes anesthesiologists, surgeons of different specialties, inten-
sive care physicians as well as specialists in transfusion medicine 
and hemostaseology. Furthermore, these programs need to be ex-
panded into nonsurgical patients such as those of internal medi-
cine, oncology, and pediatrics.
Obviously, for successfully implementing patient blood man-
agement bedside physicians are the primary target persons in order 
to avoid unnecessary allogeneic blood transfusions or their inap-
propriate application. They should be particularly educated in up-
dated transfusion policies and alternative interventions such as the 
preoperative treatment of anemia by intravenous iron and/or 
erythropoietin. Anemia is an independent risk factor for higher 
morbidity and mortality [6, 7]. Therefore, patient blood manage-
ment does not focus simply on the adherence of transfusion trig-
gers for specific patient cohorts, such as a threshold of 7 or 8 g/dl 
[8], but aims at the screening, monitoring, and treatment any kind 
of mild to severe anemia prior to surgical intervention and/or dur-
ing nonsurgical treatments if indicated [2]. 
Considering the results obtained from a variety of randomized 
clinical trials, it is time to streamline targeted therapy options ei-
ther to correct iron deficiency anemia in patients who undergo sur-
gery or to identify patients who are at risk for complications such 
as myocardial and cerebral ischemia due to severe anemia and thus 
will benefit from allogeneic blood transfusions.
By searching in the U.S. National Library of Medicine in March 
2015, surprisingly less than 100 articles titles contain the term ‘pa-
tient blood management’. Nevertheless, patient blood management 
has been received much attention worldwide in recent years, re-
sulting in hospital-based or national campaigns to educate physi-
cians and nurses in the three-pillar concept of patient blood man-
agement [1]. Like many other medical procedures, patient blood 
management aims at improving the patients’ outcome and safety. 
By then, everything seems to be business as usual, and obviously 
one might not imagine that the topic is highly charged both politi-
cally and emotionally. All stakeholders in healthcare need to over-
come the ongoing controversy about the benefit-risk ratio of blood 
transfusions. 
Patient blood management is defined as evidence-based multi-
disciplinary approach to preoperatively screen and treat patients 
for anemia, to minimize intraoperative blood loss by elaborating 
meticulous surgical techniques, individualized goal-directed coag-
ulation management and cell salvage, and finally to harness the pa-
tient’s physiological capacity for compensation of low hemoglobin 
levels prior to application of allogeneic blood transfusions [1, 2]. 
Compared with initiatives for optimal blood use with their motto 
‘transfusion of the right unit of blood to the right patient at the right 
time’, it is obvious that patient blood management is a broader 
concept covering many more issues.
The evidence-based medicine approaches are well accepted by 
the vast majority of scientists and physicians as it facilitates the 
individual decision making for diagnosis, investigation, and/or 
therapy by emphasizing different levels of evidence from well-de-
signed and well-conducted randomized clinical trials, systematic 
reviews, and meta-analyses. Patient blood management is strictly 
based on the principles of evidence-based medicine. Therefore, it 
promotes turning away from purely empirical knowledge and fos-
ters the conduction of further clinical trials with special patient 
subsets, e.g. patients with septic shock [3] and traumatic brain in-
jury [4], The results of these two studies are in line with the overall 
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Blood donation establishments and specialists in the field of 
transfusion medicine should be aware that the paradigm shift to a 
more restrictive use of allogeneic blood or its strict avoidance, if 
suitable alternatives are available, is already underway in health re-
search and healthcare nowadays [2]. We do well to strengthen our 
professional ethics to cure patients or to ameliorate illnesses and 
injuries to our best knowledge. So, voluntary blood donations and 
their state-of-the-art use is rather an issue of quality than of 
quantity.
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